CBOE : BINV

Brandes International ETF — News

$43.45 USD

-$0.05 (-0.11%)

Volume
36.13K
Average Volume
44.09K
Market Capitalization
$489.7M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$45.77
Year Low
$35.53
Day High
Day Low
Payout Ratio
Current Ratio
Source Headline
BioInvent International AB: Interim Report January - March 2026

LUND, SE / ACCESS Newswire / April 29, 2026 / BioInvent International (STO:BINV) "During the first quarter of 2026, our strategy remained centered on efficient resource allocation across our most advanced assets, BI-1808 (anti-TNFR2) and BI-1206 (anti-FcγRIIB), with the goal of advancing these innovative immune-modulatory antibodies for patients who urgently need better treatment options."- Martin Welschof, CEO of BioInvent.

accessnewswire.com - 2026-04-29 02:20:00

Get BINV Insider Trade Alerts

BINV Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

BINV Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade